Patents by Inventor Hongmei Li

Hongmei Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9828662
    Abstract: Systems and methods of a low cost, high strength titanium alloy are disclosed. According to illustrative implementations, the weight percent of the alloy composition may be: Fe content 3%˜7%, Al content 3%˜5%, C content 0.01%˜0.02%, with the balance being Ti and unavoidable impurities. Industrial pure iron, carbon steel, and industrial pure aluminum etc. may be used as the raw materials. In one exemplary method, the raw materials are mixed before being pressed to a block. The block may be double-melted to an alloy cast ingot, forged by a conventional titanium alloy forging process, and subsequently undergo a solid solution treatment of (820° C.˜950° C.)/1 h+water quenching, and an ageing treatment of (450° C.˜550° C.)/4 h+air cooling, wherein the mechanical properties of the alloy are that ?b=1000˜1250 MPa, ?=5%-12%.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: November 28, 2017
    Assignee: Beijing University of Technology
    Inventors: Bolong Li, Tong Liu, Wei Wang, Hui Huang, Hongmei Li, Li Rong
  • Patent number: 9828386
    Abstract: The present invention discloses a sulfur-substituted podophyllotoxin derivative, synthesis method thereof, and use thereof. The present invention introduces a rigid aromatic heterocyclic compound, as well as a further sulfonamidated product of 3-amino-5-mercapto-1,2,4-triazole, 2-amino-5-mercapto-1,3,4-thiadiazole, 4-methylbenzenesulfonyl chloride, or 4-methoxybenzenesulfonyl chloride as a substituent group, into position 4 of the C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the podophyllotoxin derivative shown in formula (V), said derivative having significantly increased antitumor activity and reduced toxic side effects. Experiments on in vitro tumor cell inhibition indicate that the antitumor activity of the compound of formula (V) of the present invention is significantly higher than the antitumor activity of podophyllotoxin or 4?-demethylepipodophyllotoxin.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: November 28, 2017
    Assignee: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie Tang, Jianlong Li, Wei Zhao, Hongmei Li
  • Patent number: 9775829
    Abstract: The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders and the like.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: October 3, 2017
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Bradley Teegarden, Honnappa Jayakumar, Hongmei Li, Sonja Strah-Pleynet, Peter I. Dosa
  • Publication number: 20170260518
    Abstract: Embodiment of the present invention discloses a kind of methionine lyase and its encoding gene and biosynthetic method. According to the present invention, the gene encoding methionine lyase as shown in SEQ ID No. 1 is separated from the genome of C. rosea. Embodiment of the present invention further provides an efficient biosynthetic method of methionine lyase, comprising: (1) cloning gene (shown in SEQ ID No. 1) encoding methionine degradation enzyme into a yeast expression vector to construct recombinant yeast expression vector; (2) transforming the recombinant yeast expression vector into Saccharomyces cerevisiae to obtain expression strain; (3) inducing the expression strain to express the methionine lyase, collecting induced strains, purifying expressed recombinant methionine lyase. Purity of recombinant methionine lyase prepared according to the present invention is above 90%, and its efficiency of degradating methionine can reach 0.53±0.0030 ?M MTL·h?1·mg protein?1.
    Type: Application
    Filed: December 3, 2015
    Publication date: September 14, 2017
    Applicant: Hubei University Of Technology
    Inventors: Yajie TANG, Kaizhi JIA, Yanghua XU, Quan ZHANG, Hongmei LI
  • Patent number: 9725464
    Abstract: The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: August 8, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Ian Mangion, Cheng-yi Chen, Ingyu Jeon, Yonggang Chen, Hongmei Li, Hoa N. Nguyen, Peter E. Maligres, Artis Klapars, Ilia Zavialov, Nobuyoshi Yasuda
  • Patent number: 9714254
    Abstract: The present invention discloses an anilino-substituted podophyllin derivative having antitumor activity, method for preparation thereof, and use thereof. By means of anilino reactions, the present invention introduces 4-chloro-3-methylaniline, 3-fluoro-4-methoxyaniline, 4,4?-diaminodiphenylmethane, o-anisidine, 4-chloro-2-aminoanisole, anthranilonitrile, 2,6-dichloro-4-aminophenol, N,N-dimethylamino meta-aniline, 2-ethyl-5-nitroaniline, 2 2?-diaminodiphenylsulfide, or 2-aminobenzotrifluoride into position 4 of the active C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the aniline-substituted podophyllotoxin derivative shown in formula (V); by means of multi-pathway and multi-target effects on tumor cells, said derivative has significantly increased antitumor activity, and can be prepared as an antineoplastic drug and applied in clinical antitumor therapy.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: July 25, 2017
    Assignee: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie Tang, Yong Yang, Wei Zhao, Hongmei Li
  • Publication number: 20170145014
    Abstract: The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of 1-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KRED) biocatalyst enzymes and methods of using the biocatalysts.
    Type: Application
    Filed: March 12, 2014
    Publication date: May 25, 2017
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Feng Xu, Zhuqing Liu, Richard Desmond, Jeonghan Park, Alexei Kalinin, Birgit Kosjek, Hallena Strotman, Hongmei Li, Johannah Moncecchi
  • Patent number: 9623459
    Abstract: The present invention relates to the field of strip cold rolling, and in particular to a thickness control method for strips in a tandem cold mill. Frame S1 and one or more additional frames are selected as virtual indirect measuring instruments for the strip performance. A load cell is provided on the frames that are selected as the indirect measuring instruments for the strip performance, and deformation resistance fluctuation of the supplied materials of the frame S is calculated. Finally, the feed-forward adjustment amount of each frame is calculated. The present invention measures the deformation resistance of each section of the strip of the supplied materials through the selected frame, reducing the fluctuation of the thickness of the finished products of the strip and ensuring stable rolling.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: April 18, 2017
    Assignee: BAOSHAN IRON & STEEL CO., LTD.
    Inventors: Jianghua Xu, Shanqing Li, Peijie Huang, Zhenglian Jiang, Kangjian Wang, Xin Wang, Hongmei Li
  • Publication number: 20160374990
    Abstract: The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor, Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders and the like.
    Type: Application
    Filed: February 2, 2016
    Publication date: December 29, 2016
    Inventors: Bradley Teegarden, Honnappa Jayakumar, Hongmei Li, Sonja Strah-Pleynet, Peter I. Dosa
  • Publication number: 20160289242
    Abstract: The present invention discloses an anilino-substituted podophyllin derivative having antitumor activity, method for preparation thereof, and use thereof. By means of anilino reactions, the present invention introduces 4-chloro-3-methylaniline, 3-fluoro-4-methoxyaniline, 4,4?-diaminodiphenylmethane, o-anisidine, 4-chloro-2-aminoanisole, anthranilonitrile, 2,6-dichloro-4-aminophenol, N,N-dimethylamino meta-aniline, 2-ethyl-5-nitroaniline, 2 2?-diaminodiphenylsulfide, or 2-aminobenzotrifluoride into position 4 of the active C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the aniline-substituted podophyllotoxin derivative shown in formula (V); by means of multi-pathway and multi-target effects on tumor cells, said derivative has significantly increased antitumor activity, and can be prepared as an antineoplastic drug and applied in clinical antitumor therapy.
    Type: Application
    Filed: September 5, 2014
    Publication date: October 6, 2016
    Applicant: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie TANG, Yong YANG, Wei ZHAO, Hongmei LI
  • Patent number: 9461149
    Abstract: Methods to fabricate a stacked nanowire field effect transistor (FET) with reduced gate resistance are provided. The nanowire stack in the stacked nanowire FET can be provided by first forming a material stack of alternating sacrificial material layers and nanowire material layer. The sacrificial material layers and selected nanowire material layers in the material stack are subsequently removed to increase a vertical distance between two active nanowire material layers.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: October 4, 2016
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Hongmei Li, Junjun Li, Xiaoping Liang, Kai Zhao
  • Publication number: 20160264592
    Abstract: The present invention discloses a sulfur-substituted podophyllotoxin derivative, synthesis method thereof, and use thereof. The present invention introduces a rigid aromatic heterocyclic compound, as well as a further sulfonamidated product of 3-amino-5-mercapto-1,2,4-triazole, 2-amino-5-mercapto-1,3,4-thiadiazole, 4-methylbenzenesulfonyl chloride, or 4-methoxybenzenesulfonyl chloride as a substituent group, into position 4 of the C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the podophyllotoxin derivative shown in formula (V), said derivative having significantly increased antitumor activity and reduced toxic side effects. Experiments on in vitro tumor cell inhibition indicate that the antitumor activity of the compound of formula (V) of the present invention is significantly higher than the antitumor activity of podophyllotoxin or 4?-demethylepipodophyllotoxin.
    Type: Application
    Filed: September 5, 2014
    Publication date: September 15, 2016
    Applicant: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie TANG, Jianlong LI, Wei ZHAO, Hongmei LI
  • Publication number: 20160257698
    Abstract: The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
    Type: Application
    Filed: October 24, 2014
    Publication date: September 8, 2016
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Ian Mangion, Cheng-yi Chen, Ingyu Jeon, Yonggang Chen, Hongmei Li, Hoa N. Nguyen, Peter E. Maligres, Artis Klapars, Ilia Zavialov, Nobuyoshi Yasuda
  • Publication number: 20160205939
    Abstract: The bacterium Arthrobacter ureafaciens liulou 1 (CGMCC 9667) possesses a unique combination of high atrazine-degrading activity, a capability of colonizing plant roots after seed inoculation and traits of a plant growth promoting bacterium. Also disclosed is a method of A. ureafaciens liulou 1 (CGMCC 9667) application for remediation of the polluted soils and plant protection from atrazine.
    Type: Application
    Filed: December 30, 2015
    Publication date: July 21, 2016
    Inventors: Dmitry P. Bazhanov, Hongmei Li, Chengyun Li, Jishun Li, Hetong Yang
  • Publication number: 20160190789
    Abstract: A multi-faults service restoration method for a power distribution network overcomes the defect that a traditional service restoration method for the power distribution network cannot solve multi-faults. The method includes the steps of performing multi-faults judgment on multi-faults with processing unfinished, to form many multi-faults and many single-faults; then performing unaided fault recovery area division on the multi-faults, and performing power restoration on unaided fault recovery areas one by one; and after the multi-faults are processed, performing power restoration on each single-fault.
    Type: Application
    Filed: June 19, 2014
    Publication date: June 30, 2016
    Inventors: Guofang ZHU, Hongmei LI, Jincang NIU, Baoguang ZHAO, Shangzhen LI, Xin SHI, Yong LI, Xujie LIU, Guanbin WU, Naiyuan XU, Sun LI, Yuanbin LIANG
  • Publication number: 20160163739
    Abstract: Aspects of the disclosure provide a multi-gate field effect transistor (FET) formed on a bulk substrate that includes an isolated fin and methods of forming the same. In one embodiment, the multi-gate FET includes: a plurality of silicon fin structures formed on the bulk substrate, each silicon fin structure including a body region, a source region, and a drain region; wherein a bottom portion the body region of each silicon fin structure includes a tipped shape to isolate the body region from the bulk substrate, and wherein the plurality of silicon fin structures are attached to the bulk substrate via at least a portion of the source region, or at least a portion of the drain region, or both.
    Type: Application
    Filed: February 10, 2016
    Publication date: June 9, 2016
    Inventors: Hongmei Li, Junjun Li
  • Publication number: 20160079394
    Abstract: Methods to fabricate a stacked nanowire field effect transistor (FET) with reduced gate resistance are provided. The nanowire stack in the stacked nanowire FET can be provided by first forming a material stack of alternating sacrificial material layers and nanowire material layer. The sacrificial material layers and selected nanowire material layers in the material stack are subsequently removed to increase a vertical distance between two active nanowire material layers.
    Type: Application
    Filed: September 12, 2014
    Publication date: March 17, 2016
    Inventors: Hongmei Li, Junjun Li, Xiaoping Liang, Kai Zhao
  • Patent number: 9287178
    Abstract: Aspects of the disclosure provide a multi-gate field effect transistor (FET) formed on a bulk substrate that includes an isolated fin and methods of forming the same. In one embodiment, the multi-gate FET includes: a plurality of silicon fin structures formed on the bulk substrate, each silicon fin structure including a body region, a source region, and a drain region; wherein a bottom portion the body region of each silicon fin structure includes a tipped shape to isolate the body region from the bulk substrate, and wherein the plurality of silicon fin structures are attached to the bulk substrate via at least a portion of the source region, or at least a portion of the drain region, or both.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: March 15, 2016
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Hongmei Li, Junjun Li
  • Patent number: 9273035
    Abstract: The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders and the like.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: March 1, 2016
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Bradley Teegarden, Honnappa Jayakumar, Hongmei Li, Sonja Strah-Pleynet, Peter I. Dosa
  • Publication number: 20160053251
    Abstract: The invention is directed to immobilized ketoreductases and methods of making and using them. Enzymes are protein molecules which serve to accelerate the chemical reactions of living cells (often by several orders of magnitude). Without enzymes, most biochemical reactions would be too slow to even carry out life processes. Enzymes display great specificity and are not permanently modified by their participation in reactions. Since they are not changed during the reactions, enzymes can be cost effectively used as catalysts for a desired chemical transformation.
    Type: Application
    Filed: March 12, 2014
    Publication date: February 25, 2016
    Inventors: Matthew D. Truppo, Hongmei Li, Johannah R. Moncecchi, Hallena Strotman